Vif is a 23-kDa protein encoded by human immunodeficiency virus, type 1 (HIV-1) which is important for virion infectivity. Here, we describe the phosphorylation of HIV-1 Vif and its role in HIV-1 replication. In vivo studies demonstrated that Vif is highly phosphorylated on serine and threonine residues. To identify phosphorylation sites and characterize the Vif kinase(s), Vif was expressed in Escherichia coli and purified for use as a substrate in in vitro kinase assays. The purified Vif protein was phosphorylated in vitro on serine and threonine residues by a kinase(s) present in both cytosol and membrane fractions. Phosphorylation of Vif was stimulated by phorbol 12-myristate 13-acetate and inhibited by staurosporine and hypericin, a drug with potent anti-HIV activity. The Vif kinase(s) was resistant to inhibitors of protein kinase C, cAMP-dependent kinase, and cGMP-dependent kinase, suggesting that it is distinct from these enzymes. To identify the phosphorylation sites, P-labeled Vif was digested by V8 protease and the peptides were resolved by reverse-phase high performance liquid chromatography. Radioactive peptide sequencing identified three phosphorylation sites within the C terminus, Ser, Thr, and Thr. Two-dimensional tryptic phosphopeptide mapping indicated that these sites are also phosphorylated in vivo. Both Ser and Thr are contained in the recognition motifs (R/KXXS/T and R/KXXXS/T) used by serine/threonine protein kinases such as cGMP-dependent kinase and PKC. Ser is present in the motif SLQXLA, which is the most highly conserved sequence among all lentivirus Vif proteins. Mutation of Ser to alanine resulted in loss of Vif activity and >90% inhibition of HIV-1 replication. These studies suggest that phosphorylation of Vif by a serine/threonine protein kinase(s) plays an important role in regulating HIV-1 replication and infectivity.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Y.-S. Chen, W.-H. Huang, S.-Y. Hong, Y.-G. Tsay, and P.-J. Chen ERK1/2-Mediated Phosphorylation of Small Hepatitis Delta Antigen at Serine 177 Enhances Hepatitis Delta Virus Antigenomic RNA Replication J. Virol., October 1, 2008; 82(19): 9345 - 9358. [Abstract] [Full Text] [PDF]

				S. Bernacchi, S. Henriet, P. Dumas, J.-C. Paillart, and R. Marquet RNA and DNA Binding Properties of HIV-1 Vif Protein: A FLUORESCENCE STUDY J. Biol. Chem., September 7, 2007; 282(36): 26361 - 26368. [Abstract] [Full Text] [PDF]

				S. Henriet, L. Sinck, G. Bec, R. J. Gorelick, R. Marquet, and J.-C. Paillart Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription Nucleic Acids Res., August 1, 2007; 35(15): 5141 - 5153. [Abstract] [Full Text] [PDF]

				Y.-K. Shin, Q. Liu, S. K. Tikoo, L. A. Babiuk, and Y. Zhou Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation J. Gen. Virol., March 1, 2007; 88(3): 942 - 950. [Abstract] [Full Text] [PDF]

				I. Paul, J. Cui, and E. L. Maynard Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein-protein interactions PNAS, December 5, 2006; 103(49): 18475 - 18480. [Abstract] [Full Text] [PDF]

				C. Pace, J. Keller, D. Nolan, I. James, S. Gaudieri, C. Moore, and S. Mallal Population Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic Variation. J. Virol., September 1, 2006; 80(18): 9259 - 9269. [Abstract] [Full Text] [PDF]

				M. Santa-Marta, F. A. da Silva, A. M. Fonseca, and J. Goncalves HIV-1 Vif Can Directly Inhibit Apolipoprotein B mRNA-editing Enzyme Catalytic Polypeptide-like 3G-mediated Cytidine Deamination by Using a Single Amino Acid Interaction and Without Protein Degradation J. Biol. Chem., March 11, 2005; 280(10): 8765 - 8775. [Abstract] [Full Text] [PDF]

				A. C. Ribeiro, A. Maia e Silva, M. Santa-Marta, A. Pombo, J. Moniz-Pereira, J. Goncalves, and I. Barahona Functional Analysis of Vif Protein Shows Less Restriction of Human Immunodeficiency Virus Type 2 by APOBEC3G J. Virol., January 15, 2005; 79(2): 823 - 833. [Abstract] [Full Text] [PDF]

				A. Mehle, J. Goncalves, M. Santa-Marta, M. McPike, and D. Gabuzda Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation Genes & Dev., December 1, 2004; 18(23): 2861 - 2866. [Abstract] [Full Text] [PDF]

				S. de Rozieres, C. K. Mathiason, M. R. Rolston, U. Chatterji, E. A. Hoover, and J. H. Elder Characterization of a Highly Pathogenic Molecular Clone of Feline Immunodeficiency Virus Clade C J. Virol., September 1, 2004; 78(17): 8971 - 8982. [Abstract] [Full Text] [PDF]

				M. Esfandiarei, H. Luo, B. Yanagawa, A. Suarez, D. Dabiri, J. Zhang, and B. M. McManus Protein Kinase B/Akt Regulates Coxsackievirus B3 Replication through a Mechanism Which Is Not Caspase Dependent J. Virol., April 15, 2004; 78(8): 4289 - 4298. [Abstract] [Full Text] [PDF]

				A. Mehle, B. Strack, P. Ancuta, C. Zhang, M. McPike, and D. Gabuzda Vif Overcomes the Innate Antiviral Activity of APOBEC3G by Promoting Its Degradation in the Ubiquitin-Proteasome Pathway J. Biol. Chem., February 27, 2004; 279(9): 7792 - 7798. [Abstract] [Full Text] [PDF]

				L. Baraz, M. Hutoran, I. Blumenzweig, M. Katzenellenbogen, A. Friedler, C. Gilon, M. Steinitz, and M. Kotler Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region J. Gen. Virol., September 1, 2002; 83(9): 2225 - 2230. [Abstract] [Full Text] [PDF]

				J. Goncalves, F. Silva, A. Freitas-Vieira, M. Santa-Marta, R. Malho, X. Yang, D. Gabuzda, and C. Barbas III Functional Neutralization of HIV-1 Vif Protein by Intracellular Immunization Inhibits Reverse Transcription and Viral Replication J. Biol. Chem., August 23, 2002; 277(35): 32036 - 32045. [Abstract] [Full Text] [PDF]

				M. A. Khan, H. Akari, S. Kao, C. Aberham, D. Davis, A. Buckler-White, and K. Strebel Intravirion Processing of the Human Immunodeficiency Virus Type 1 Vif Protein by the Viral Protease May Be Correlated with Vif Function J. Virol., August 12, 2002; 76(18): 9112 - 9123. [Abstract] [Full Text] [PDF]

				B. Muller, T. Patschinsky, and H.-G. Krausslich The Late-Domain-Containing Protein p6 Is the Predominant Phosphoprotein of Human Immunodeficiency Virus Type 1 Particles J. Virol., February 1, 2002; 76(3): 1015 - 1024. [Abstract] [Full Text] [PDF]

				M. Bardy, B. Gay, S. Pebernard, N. Chazal, M. Courcoul, R. Vigne, E. Decroly, and P. Boulanger Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing J. Gen. Virol., November 1, 2001; 82(11): 2719 - 2733. [Abstract] [Full Text] [PDF]

				U. Chatterji, C. K. Grant, and J. H. Elder Feline Immunodeficiency Virus Vif Localizes to the Nucleus J. Virol., March 15, 2000; 74(6): 2533 - 2540. [Abstract] [Full Text]

				C. Cartier, P. Sivard, C. Tranchat, D. Decimo, C. Desgranges, and V. Boyer Identification of Three Major Phosphorylation Sites within HIV-1 Capsid. ROLE OF PHOSPHORYLATION DURING THE EARLY STEPS OF INFECTION J. Biol. Chem., July 2, 1999; 274(27): 19434 - 19440. [Abstract] [Full Text] [PDF]

				J. H. M. Simon, A. M. Sheehy, E. A. Carpenter, R. A. M. Fouchier, and M. H. Malim Mutational Analysis of the Human Immunodeficiency Virus Type 1 Vif Protein J. Virol., April 1, 1999; 73(4): 2675 - 2681. [Abstract] [Full Text]

				X. Yang and D. Gabuzda Mitogen-activated Protein Kinase Phosphorylates and Regulates the HIV-1 Vif Protein J. Biol. Chem., November 6, 1998; 273(45): 29879 - 29887. [Abstract] [Full Text] [PDF]

				V. R. K. Yedavalli, C. Chappey, E. Matala, and N. Ahmad Conservation of an Intact vif Gene of Human Immunodeficiency Virus Type 1 during Maternal-Fetal Transmission J. Virol., February 1, 1998; 72(2): 1092 - 1102. [Abstract] [Full Text] [PDF]